Delivery of immune response modifier compounds

Details Delivery of immune response modifier compounds Delivery of immune response modifier compounds

2011-04-12

2011-04-12

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S118000, C546S080000, C514S293000, C514S300000

Reexamination Certificate

active

07923560

ABSTRACT:
The present invention provides immune response modifiers (IRMs) associated with (typically, attached to, and preferably, covalently attached to) macromolecular support materials. The IRM compounds in such IRM-support complexes retain biological activity. Such attachment of an IRM to a macromolecular support material provides for the localized biological activity of the IRM.

REFERENCES:
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5078978 (1992-01-01), Tarbet et al.
patent: 5175296 (1992-12-01), Gerster
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gerster
patent: 5342940 (1994-08-01), Ono et al.
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5367076 (1994-11-01), Gerster
patent: 5376501 (1994-12-01), Mariën et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5447724 (1995-09-01), Helmus et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5494916 (1996-02-01), Lindstrom et al.
patent: 5525612 (1996-06-01), Gerster
patent: 5605899 (1997-02-01), Gerster et al.
patent: 5693811 (1997-12-01), Lindstrom
patent: 5741908 (1998-04-01), Gerster et al.
patent: 5756747 (1998-05-01), Gerster
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6028076 (2000-02-01), Hirota et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6069149 (2000-05-01), Nanba et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6194388 (2001-02-01), Krieg et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6273913 (2001-08-01), Wright et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6323200 (2001-11-01), Gerster et al.
patent: 6329381 (2001-12-01), Kurimoto et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6339068 (2002-01-01), Krieg et al.
patent: 6376501 (2002-04-01), Isobe et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6387938 (2002-05-01), Mizuguchi et al.
patent: 6406705 (2002-06-01), Davis et al.
patent: 6426334 (2002-07-01), Agrawal et al.
patent: 6440992 (2002-08-01), Gerster et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6476000 (2002-11-01), Agrawal
patent: 6486168 (2002-11-01), Skwierczynski et al.
patent: 6486214 (2002-11-01), Uhrich
patent: 6514985 (2003-02-01), Gerster et al.
patent: 6518265 (2003-02-01), Kato et al.
patent: 6518280 (2003-02-01), Gerster et al.
patent: 6525028 (2003-02-01), Johnson et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6582938 (2003-06-01), Su et al.
patent: 6649172 (2003-11-01), Johnson
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6894060 (2005-05-01), Slade
patent: 7030129 (2006-04-01), Miller et al.
patent: 2002/0016332 (2002-02-01), Slade
patent: 2002/0022721 (2002-02-01), Trulson et al.
patent: 2002/0055517 (2002-05-01), Smith
patent: 2002/0058674 (2002-05-01), Hedenstrom et al.
patent: 2002/0110840 (2002-08-01), Tomai et al.
patent: 2003/0133913 (2003-07-01), Tomai et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0144283 (2003-07-01), Coleman et al.
patent: 2003/0199461 (2003-10-01), Averett et al.
patent: 2004/0010007 (2004-01-01), Dellaria et al.
patent: 0386767 (1990-09-01), None
patent: 0 394 026 (1990-10-01), None
patent: 1 104 764 (2001-06-01), None
patent: 9-208584 (1997-08-01), None
patent: 11-80156 (1999-03-01), None
patent: 11-222432 (1999-08-01), None
patent: 2000-247884 (2000-09-01), None
patent: WO 00/47719 (2000-08-01), None
patent: WO 00/75304 (2000-12-01), None
patent: WO 00/76505 (2000-12-01), None
patent: WO 00/76518 (2000-12-01), None
patent: 01/00242 (2001-01-01), None
patent: 03/034944 (2001-01-01), None
patent: WO 0123067 (2001-05-01), None
patent: WO 01/68144 (2001-09-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 02/46188 (2002-06-01), None
patent: WO 02/46189 (2002-06-01), None
patent: WO 02/46190 (2002-06-01), None
patent: WO 02/46191 (2002-06-01), None
patent: WO 02/46192 (2002-06-01), None
patent: WO 02/46193 (2002-06-01), None
patent: WO 02/46194 (2002-06-01), None
patent: WO 02/46749 (2002-06-01), None
patent: WO 02/085905 (2002-10-01), None
patent: WO 02/092118 (2002-11-01), None
patent: 02/102825 (2002-12-01), None
patent: WO 02/102377 (2002-12-01), None
patent: WO 03/020889 (2003-03-01), None
patent: WO 03/043572 (2003-05-01), None
patent: WO 03/045391 (2003-06-01), None
patent: WO 03/103584 (2003-12-01), None
patent: 2004/060967 (2004-07-01), None
patent: WO 2005/109313 (2005-11-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Langer, 1990, New methods of Drug Delivery. pp. 1527-1533.
Testerman, et al., “Cytokine Induction by the Immunomodulators Imiquimod and S-27609”,Journal of Leukocyte Biology, vol. 58, pp. 365-372, Sep. 1995.
Chollet, et al, “Development of a Topically Active Imiquimod Formulation”,Pharmaceutical Development and Technology, 4(1), pp. 35-43 (1999).
Brassard et al.; “Interferon-α as an immunotherapeutic protein”; Journal of Leukocyte Biology; vol. 71; Apr. 2002; pp. 565-581.
Izumi et al.; “1H-imidazo[4,5-c]quinoline Derivatives as Novel Potent TNF-α Suppressors: Synthesis and Structure-Activity Relationship of 1-, 2-and 4-Substituted 1H-imidazo[4,5-c]quinolines or 1Himidazo[4,5-c]Pyridines”;Bioorganic and Medicinal Chemistry, vol. 11. pp. 2541-2550 (2003).
Drachman, “Clinical Experience with Drug-Eluting Stents,” Rev Cardiovasc Med. 2002;3 (suppl 5): S31-S37.
Heldman et al., “Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis,” Circulation. 2001; 103: 2289-2295.
Lepor et al., “Effective and Efficient Strategies for Coronary Revascularization in the Drug-Eluting Stent Era,” Rev Cardiovasc Med. 2002;3 (suppl 5): S38-S50).
Rensing et al., “Coronary restenosis elimination with a sirolimus eluting stent, First European human experience with 6-month angiographic and intravascular follow-up,” Eur. Heart J. 2001; 22: 2125-2130.
Rogers, “Drug-Eluting Stents: Role of Stent Design, Delivery Vehicle, and Drug Selection, ”Rev Cardiovasc Med. 2002; 3 (suppl 5): S10-S15.
Schwartz et al., “Pathophysiology of Coronary Artery Restenosis,” Rev Cardiovasc Med. 2002; 3 (suppl 5): S4-S9.
Sousa et al., “Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents, One-Year Angiographic and Intravascular Ultrasound Follow-up,” Circulation, 2001; 104: 2007-2011.
Gibson S. J. et al., “Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod”Cellular Immunologyvol. 218, pp. 74-86 (2002).
The Merck Index, An encyclopedia of chemicals, drugs, and biologicals 13thEdition, 2001, Merck & Co., Inc., Whitehouse Station

Affiliated with

Also associated with

Rating

Delivery of immune response modifier compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Delivery of immune response modifier compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery of immune response modifier compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2649857